These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34840657)

  • 21. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
    Bailey AJM; Li HO; Tan MG; Cheng W; Dover JS
    J Am Acad Dermatol; 2022 Apr; 86(4):797-810. PubMed ID: 33857549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Topical Tranexamic Acid Alone or in Combination with Either Fractional Carbon Dioxide Laser or Microneedling for the Treatment of Melasma.
    Mamdouh Kamal Dawaud S; Hegab DS; Mohamed El Maghraby G; Ahmad El-Ashmawy A
    Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microneedling with glutathione versus microneedling alone in treatment of facial melasma: Split-face comparative study.
    Mohamed M; Beshay YMA; Assaf HM
    J Cosmet Dermatol; 2023 Dec; 22(12):3379-3386. PubMed ID: 37313658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tranexamic acid in melasma: A focused review on drug administration routes.
    Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microneedling-assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: A split-face randomized study.
    Zaky MS; Obaid ZM; Khalil EA; Elsaie ML
    J Cosmet Dermatol; 2021 Dec; 20(12):4011-4016. PubMed ID: 34525492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
    Tekam PS; Belgaumkar VA
    Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-Rich Plasma in Melasma-A Systematic Review.
    Sarkar R; Gupta M
    Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
    Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
    J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
    Polat Y; Saraç G
    Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
    Gamea MM; Kamal DA; Donia AA; Hegab DS
    J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study.
    Tahoun AI; Mostafa WZ; Amer MA
    J Dermatolog Treat; 2022 May; 33(3):1623-1629. PubMed ID: 33393842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
    Kaur A; Bhalla M; Pal Thami G; Sandhu J
    Dermatol Surg; 2020 Nov; 46(11):e96-e101. PubMed ID: 32769524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis.
    Zhao L; Hu M; Xiao Q; Zhou R; Li Y; Xiong L; Li L
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1587-1597. PubMed ID: 34269967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
    Adel S; Serri A; Abd El-Raheem T
    Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma.
    Hofny ERM; Hussein MRA; Ghazally A; Ahmed AM; Abdel-Motaleb AA
    J Cosmet Laser Ther; 2019; 21(7-8):382-389. PubMed ID: 31554441
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single-blind randomized clinical trial.
    Shamsi Meymandi S; Mozayyeni A; Shamsi Meymandi M; Aflatoonian M
    J Cosmet Dermatol; 2020 Nov; 19(11):2906-2911. PubMed ID: 32406162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical 10% Tranexamic Acid with and without Microneedling in the Treatment of Erythematotelangiectatic Rosacea: A Split-face Comparative Study.
    Mohamed RR; Mahmoud Mohamed LG; Mansour M; Rageh MA
    J Clin Aesthet Dermatol; 2024 Feb; 17(2):47-51. PubMed ID: 38444423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microneedling with cutaneous delivery of topical agents for the treatment of melasma: A systematic review.
    Brasil Dos Santos J; Nagem Lopes LP; de Lima GG; Teixeira da Silva R; da Silva E Souza Lorca B; Miranda Pinheiro G; Faria de Freitas ZM
    J Cosmet Dermatol; 2022 Nov; 21(11):5680-5695. PubMed ID: 35933690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.